NET PROFIT (x1000 NOK)
EMPLOYEES
Empire Bio A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-409
|
-157
|
215 |
| Total assets |
11,194
|
12,370
|
14,740 |
| Current assets |
3,378
|
5,286
|
7,314 |
| Current liabilities |
4,096
|
5,363
|
7,952 |
| Equity capital |
6,877
|
6,752
|
6,510 |
| - share capital |
2,081
|
1,953
|
1,851 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
61.4%
|
54.6%
|
44.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
82.5%
|
98.6%
|
92.0% |
| Return on equity (ROE) |
-5.9%
|
-2.3%
|
3.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.